… cancer patients is not completely known. In recent years, convincing evidence supports the
management of fatigue … would decrease fatigue in cancer patients receiving cytotoxic drugs at …

… is a significant and distressing problem for the cancer patient, affecting their physical and …
fatigue in cancer outpatients receiving cytotoxic drugs, using an existing international fatigue …

… may interact with other common adverse effects of chemotherapy drugs… cancer patients
treated with radiotherapy although such patients typically report more fatigue than chemotherapy …

… or total lack of energy that can last for days, weeks or months; commonly caused by anaemia,
fatigue is the side effect of chemotherapy that affects patients the most –more than nausea, …

… As an example, a strategy of energy conservation and activity management (ECAM) was
studied in 396 fatigued cancer patients initiating chemotherapy or radiotherapy who were …

… A nonprobability sample of 109 cancer patients receiving either single-agent chemotherapy
or a combination treatment with cytotoxic drugs provided data for this investigation. …

… The pathophysiology of fatigue is still not well understood although fatigue symptoms
following cancer and cytotoxic drug treatment have been well-known since long. The symptoms …

… value in reducing cancer-related fatigue symptoms, … cancer or cancer treatment. A particular
intervention, for example, may be more effective for radiation therapy than for cytotoxic drug …

… Potential factors contributing to fatigue are the cancer itself, cancer treatment, cancer or
treatment complications, medications, and other physical … Many fatigue assessment tools exist. …

… 11,525 patients, with half of the sample involved breast cancer exclusively. Exercise and
psychological intervention were effective in reducing fatigue during and after cancer treatment …